Skip to main content
. 2020 Oct;6(5):a005678. doi: 10.1101/mcs.a005678

Figure 4.

Figure 4.

Schema of JAK1 function impacting mutations leading to immunotherapy resistance. (JAK) Janus kinase, (PD-L1) programmed death-ligand 1, (PARPi) Poly (ADP-ribose) polymerase inhibition, (dMMR) mismatch repair deficiency, (IO) immune checkpoint blockade, (mt) mutant, (TILs) tumor infiltrating lymphocytes, (ISGs) interferon stimulated genes.